Switzerland

Kapsch TrafficCom Secures Contract for Swiss HGV Road Fee Collection System Until 2032

(IN BRIEF) Kapsch TrafficCom has been awarded a contract by the Swiss Federal Office for Customs and Border Security (BAZG)…

2 years ago

Holcim Reports Robust Q1 Performance with Over-Proportional Growth and Strategic Expansion

(IN BRIEF) Holcim, a global leader in building solutions, announced its first-quarter 2024 results, showcasing strong growth and strategic expansion.…

2 years ago

Sika Expands in Latin America with New Synthetic Macro Fiber Facility in Peru

(IN BRIEF) Sika is establishing a cutting-edge facility in Lima, Peru, to manufacture synthetic macro fibers, further solidifying its position…

2 years ago

Kuehne+Nagel Group Sees Q1 Earnings Dip Amid Strategic Measures

(IN BRIEF) In the first quarter of 2024, Kuehne+Nagel Group reported a decline in earnings compared to the previous year,…

2 years ago

Swissloop Tunneling Triumphs at Not-a-Boring Competition 2024 with Groundhog Beta

(IN BRIEF) Swissloop Tunneling, a team of students from ETH Zurich supported by Empa, emerged victorious at the Not-a-Boring Competition…

2 years ago

Siemens and BILT Revolutionize Electrician Training with Immersive Spatial Models on Apple Vision Pro

(IN BRIEF) Siemens and BILT are pioneering a groundbreaking approach to electrician training by optimizing their 3D Intelligent Instructions for…

2 years ago

Ingka Group Expands Globally with New IKEA Store Openings in Switzerland and China

(IN BRIEF) Ingka Group, the leading IKEA retailer, is embarking on an ambitious expansion journey by opening new IKEA stores…

2 years ago

Siemens Unveils Electrification X: Revolutionizing Infrastructure Transformation

(IN BRIEF) Siemens Smart Infrastructure has introduced Electrification X, the latest addition to its Xcelerator portfolio, aiming to revolutionize the…

2 years ago

Long-Term Study Shows Sustained Efficacy of Kesimpta in Treating Relapsing Multiple Sclerosis

(IN BRIEF) Novartis revealed promising data from the ALITHIOS open-label extension study, highlighting the enduring effectiveness of Kesimptaยฎ (ofatumumab) in…

2 years ago